SCHEMBL21397097

SCHEMBL21397097

N#Cc1c(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)cc(-c2ccc(-n3c4ccccc4c4ncccc43)cc2)cc1-n1c2ccccc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP11B2 P19099 1/20 0.34
ALDH1A1 P00352 4/20 0.32
HTT P42858 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TSPO P30536 1/20 0.32
HDAC4 P56524 1/20 0.32
PGR P06401 1/20 0.31
NPY5R Q15761 1/20 0.31
HPGD P15428 2/20 0.30
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
AKR1C4 P17516 1/20 0.30
AKR1C3 P42330 1/20 0.30
AKR1C2 P52895 1/20 0.30
AKR1C1 Q04828 1/20 0.30
GAA P10253 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21396581 0.99 CYP11B2 (0.34) KDM4EATML3MBTL1CYP11B2ALDH1A1
SCHEMBL21396876 0.95 KDM4E (0.34) KDM4EATML3MBTL1CYP11B2ALDH1A1
SCHEMBL21397086 0.93 CYP11B2 (0.33) KDM4EATML3MBTL1CYP11B2ALDH1A1
SCHEMBL21378041 0.90 PDE9A (0.35) KDM4EATML3MBTL1CYP11B2ALDH1A1
SCHEMBL21396835 0.90 ALDH1A1 (0.37) KDM4EATML3MBTL1CYP11B2ALDH1A1
SCHEMBL21396578 0.88 KDM4E (0.33) KDM4EATML3MBTL1CYP11B2ALDH1A1
SCHEMBL21396827 0.87 ALDH1A1 (0.38) KDM4ECYP11B2ALDH1A1HTTHSD17B10
SCHEMBL23983334 0.87 CYP11B2 (0.33) KDM4EATML3MBTL1CYP11B2ALDH1A1
SCHEMBL23979311 0.86 CYP11B2 (0.33) KDM4EATML3MBTL1CYP11B2ALDH1A1
SCHEMBL17349397 0.85 KDM4E (0.45) KDM4EATML3MBTL1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 KDM4E 4364/4885ATM 1817/4885L3MBTL1 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.